FRA:IUI1 - Deutsche Boerse Ag - US46120E6023 - Common Stock - Currency: EUR
FRA:IUI1 (5/23/2025, 7:00:00 PM)
476.6
-5.3 (-1.1%)
The current stock price of IUI1.DE is 476.6 EUR. In the past month the price increased by 7.44%. In the past year, price increased by 27.3%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
1ABT.MI | ABBOTT LABORATORIES | 28 | 206.07B | ||
ABL.DE | ABBOTT LABORATORIES | 27.34 | 201.20B | ||
1ISRG.MI | INTUITIVE SURGICAL INC | 73.88 | 179.01B | ||
BSX.DE | BOSTON SCIENTIFIC CORP | 38.66 | 136.70B | ||
1MDT.MI | MEDTRONIC PLC | 15.68 | 97.91B | ||
2M6.DE | MEDTRONIC PLC | 14.57 | 90.98B | ||
SHL.DE | SIEMENS HEALTHINEERS AG | 20.58 | 52.46B | ||
BOX.DE | BECTON DICKINSON AND CO | 12.05 | 43.08B | ||
EWL.DE | EDWARDS LIFESCIENCES CORP | 28.57 | 38.54B | ||
DC4.DE | DEXCOM INC | 51.18 | 29.30B | ||
1PHIA.MI | KONINKLIJKE PHILIPS NV | 15.64 | 20.28B | ||
PHIA.AS | KONINKLIJKE PHILIPS NV | 14.54 | 18.86B |
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California and currently employs 15,638 full-time employees. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
INTUITIVE SURGICAL INC
1020 Kifer Road
Sunnyvale CALIFORNIA US
Employees: 15638
Phone: 14085232100
The current stock price of IUI1.DE is 476.6 EUR. The price decreased by -1.1% in the last trading session.
The exchange symbol of INTUITIVE SURGICAL INC is IUI1 and it is listed on the Deutsche Boerse Ag exchange.
IUI1.DE stock is listed on the Deutsche Boerse Ag exchange.
39 analysts have analysed IUI1.DE and the average price target is 525.09 EUR. This implies a price increase of 10.17% is expected in the next year compared to the current price of 476.6. Check the INTUITIVE SURGICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
INTUITIVE SURGICAL INC (IUI1.DE) has a market capitalization of 170.82B EUR. This makes IUI1.DE a Large Cap stock.
INTUITIVE SURGICAL INC (IUI1.DE) currently has 15638 employees.
INTUITIVE SURGICAL INC (IUI1.DE) has a support level at 443.3 and a resistance level at 494.89. Check the full technical report for a detailed analysis of IUI1.DE support and resistance levels.
The Revenue of INTUITIVE SURGICAL INC (IUI1.DE) is expected to grow by 18.08% in the next year. Check the estimates tab for more information on the IUI1.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
IUI1.DE does not pay a dividend.
INTUITIVE SURGICAL INC (IUI1.DE) will report earnings on 2025-07-16, after the market close.
The PE ratio for INTUITIVE SURGICAL INC (IUI1.DE) is 70.5. This is based on the reported non-GAAP earnings per share of 6.76 and the current share price of 476.6 EUR. Check the full fundamental report for a full analysis of the valuation metrics for IUI1.DE.
ChartMill assigns a technical rating of 6 / 10 to IUI1.DE. When comparing the yearly performance of all stocks, IUI1.DE is one of the better performing stocks in the market, outperforming 75.56% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to IUI1.DE. IUI1.DE has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
Over the last trailing twelve months IUI1.DE reported a non-GAAP Earnings per Share(EPS) of 6.76. The EPS increased by 27.76% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 27.81% | ||
ROA | 12.39% | ||
ROE | 14.05% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 79% to IUI1.DE. The Buy consensus is the average rating of analysts ratings from 39 analysts.
For the next year, analysts expect an EPS growth of 8.84% and a revenue growth 18.08% for IUI1.DE